Endurance Wealth Management, Inc. / EW
Endurance Wealth Management, Inc.’s Edwards Lifesciences Corp Position
Does Endurance Wealth Management, Inc. own Edwards Lifesciences Corp (EW)? Yes — 231.1K shares worth $22M (+2.98% of its 13F portfolio) as of Q2 2023, down from 231.5K shares the prior filed quarter.
Position Value
$22M
Q2 2023
Shares
231.1K
% of Portfolio
+2.98%
Quarters Held
19
currently held
Position History EW
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q2 2023 | 231.1K | $22M | +2.98% |
| Q1 2023 | 231.5K | $19M | +2.71% |
| Q4 2022 | 232.2K | $17M | +2.61% |
| Q3 2022 | 234.7K | $19M | +3.20% |
| Q2 2022 | 235.4K | $22M | +3.40% |
| Q1 2022 | 236.0K | $28M | +3.59% |
| Q4 2021 | 230.1K | $30M | +3.21% |
| Q3 2021 | 235.5K | $27M | +2.97% |
| Q2 2021 | 239.8K | $25M | +2.75% |
| Q1 2021 | 241.8K | $20M | +2.38% |
| Q4 2020 | 243.0K | $22M | +2.80% |
| Q3 2020 | 244.4K | $20M | +2.87% |
| Q2 2020 | 248.0K | $17M | +2.81% |
| Q1 2020 | 83.3K | $16M | +3.02% |
| Q4 2019 | 84.0K | $20M | +3.00% |
| Q3 2019 | 84.3K | $19M | +3.08% |
| Q2 2019 | 88.4K | $16M | +2.57% |
| Q1 2019 | 89.1K | $17M | +2.79% |
| Q4 2018 | 90.9K | $14M | +2.59% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Endurance Wealth Management, Inc.’s full portfolio or all institutional holders of EW.